Xianquan Zhan

Shandong First Medical University

Xianquan Zhan received his MD and Ph.D. in Preventive Medicine from the West China University of Medical Sciences. He received his post-doctoral training in oncology and cancer proteomics at Central South University, China, and the University of Tennessee Health Science Center (UTHSC), USA. He worked at UTHSC and the Cleveland Clinic during 2001-2012, and achieved the rank of associate professor at UTHSC. Currently, he is a full professor at Central South University and Shandong First Medical University, as well as an advisor to MS/Ph.D. graduate students and postdoctoral fellows. Dr. Zhan is a fellow of the Royal Society of Medicine and the European Association for Predictive, Preventive & Personalized Medicine (EPMA), a national representative for EPMA, and a member of the American Society of Clinical Oncology (ASCO) and the American Association for the Advancement of Sciences (AAAS). He is editor in chief of the International Journal of Chronic Diseases & Therapy, associate editor of EPMA Journal and BMC Medical Genomics, and guest editor of Frontiers in Endocrinology, Mass Spectrometry Reviews, EPMA Journal, and Oxidative Medicine and Cellular Longevity. He has published more than 140 articles, twenty-five book chapters, five books, and two US patents in the field of clinical proteomics and biomarkers.

3books edited

9chapters authored

Latest work with IntechOpen by Xianquan Zhan

Metabolomics is the methodology and theory to study the metabolome, including targeted approaches based on selected/multiple reaction monitoring (SRM/MRM) and untargeted approaches based on nuclear magnetic resonance (NMR) or mass spectrometry (MS). The metabolome contains all metabolites derived from sugars, lipids, proteins, and nucleic acids in a given biological system, tissue, cell, or body fluid in a metabolic network system. Metabolomic variations directly link to molecular mechanisms of a disease, reliable therapeutic targets, and effective biomarkers for prediction, diagnosis, and prognostic assessment of disease. This book presents new advances in the concept and methodology of metabolomics, as well as applications of metabolomics in the research and practice of medical and life sciences.

Go to the book